BIB Share Price

Open 47.22 Change Price %
High 47.87 1 Day 1.41 3.05
Low 47.07 1 Week 1.25 2.69
Close 47.68 1 Month 0.38 0.80
Volume 511572 1 Year -1.20 -2.45
52 Week High 52.80
52 Week Low 33.97
BIB Important Levels
Resistance 2 48.42
Resistance 1 48.12
Pivot 47.54
Support 1 47.24
Support 2 46.94
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
SIRI 5.13 1.18%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
CYTR 0.83 36.07%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
CPSL 0.09 50.00%
LOCM 0.09 50.00%
RITT 0.03 50.00%
OPTT 2.74 49.73%
CYTR 0.83 36.07%
WRES 0.09 28.57%
BSDM 0.62 26.53%
ATRM 1.89 26.00%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

ProShares Trust ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)

BIB Technical Analysis 1.5
As on 24th Apr 2017 BIB Share Price closed @ 47.68 and we RECOMMEND Buy for LONG-TERM with Stoploss of 45.21 & Sell for SHORT-TERM with Stoploss of 47.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIB Target for April
1st Target up-side 51.33
2nd Target up-side 53.48
3rd Target up-side 55.63
1st Target down-side 45.19
2nd Target down-side 43.04
3rd Target down-side 40.89
BIB Other Details
Segment EQ
Market Capital 32778000.00
Sector Finance - General
Industry
Offical website
BIB Address
BIB
BIB Latest News
Upside Coming for Biotech ETFs Against Challenging Political Backdrop   ETF Trends   - 30th Mar 17
Pharma industry thumbs up on FDA pick Gottlieb   Seeking Alpha   - 16th Mar 17
Third-Largest Biotech ETF Up 20% Year-to-Date   ETF Trends   - 14th Mar 17
Time to Get Back Into Biotech ETFs?   SmallCap Network   - 22nd Mar 16
Only 9% Of Nasdaq Biotechnology Stocks Are Good Value: I Am Shorting The ...   Seeking Alpha   - 07th Oct 15
Guide to Inverse & Leveraged Biotech ETF Investing   Nasdaq   - 25th Sep 15
Biotech ETF Slide Likely To Continue   ETF Daily News   - 24th Sep 15
More Triple-Leveraged Biotech ETFs Come to Town   ETF Trends   - 23rd Jun 15
3 Biotech ETFs Crushing the Market in 2015   Zacks.com   - 13th Mar 15
The Best Biotech ETF To Buy and One To Avoid [iShares NASDAQ Biotechnology ...   ETF Daily News   - 15th Oct 14
Interactive Technical Analysis Chart ProShares Trust ProShares Ultra Nasdaq Biotechnology ( BIB NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ProShares Trust ProShares Ultra Nasdaq Biotechnology
BIB Business Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.